For the quarter ending 2026-03-31, KIDS had -$7,375K decrease in cash & cash equivalents over the period. -$5,047K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -10,687 | -10,103 | -11,773 | -17,772 |
| Goodwill and other intangible asset impairments | - | 2,349 | 4,163 | - |
| Depreciation and amortization | 5,721 | 5,602 | 5,299 | 10,218 |
| Loss on early extinguishment of debt | - | 0 | 0 | - |
| Stock-based compensation | 3,982 | 4,416 | 4,251 | 9,111 |
| Fair value adjustment of contingent consideration | - | 0 | - | - |
| Accretion of acquisition installment payable | 72 | -16 | 7 | 98 |
| Deferred income taxes | -314 | -273 | -125 | 245 |
| Non-cash other | 50 | 332 | 12 | -100 |
| Accounts receivable - trade | 183 | 1,096 | -3,111 | 11,381 |
| Inventories | -139 | 576 | -1,006 | 8,899 |
| Prepaid expenses and other current assets | 483 | -238 | -677 | 501 |
| Accounts payable - trade | 704 | 10,128 | -5,681 | 3,720 |
| Accrued expenses and other liabilities | -3,571 | 458 | -1,719 | 2,509 |
| Other | -1,283 | 1,111 | -191 | 1,866 |
| Net cash used in operating activities | -3,287 | 10,348 | -581 | -14,618 |
| Acquisition of boston o&p, net of cash acquired | - | 0 | 0 | 0 |
| Other acquisitions, including clinics, net of cash acquired | 6,777 | 6,650 | 8,532 | 320 |
| Acquisition of medtech, net of cash acquired | - | -2,007 | 467 | 1,540 |
| Acquisition of rhino assets | - | 0 | - | - |
| Sale of short-term marketable securities | 5,000 | 0 | 0 | 0 |
| Purchase of short-term marketable securities | - | 0 | 15,000 | - |
| Investment in private companies and purchases of licenses | 250 | 2,017 | - | - |
| Purchases of property and equipment | 1,760 | 599 | 2,839 | 7,672 |
| Net cash used in investing activities | -3,787 | -7,259 | -26,838 | -9,532 |
| Proceeds from issuance of debt | - | 0 | 0 | 25,000 |
| Payment of debt issuance costs | - | 0 | 0 | 0 |
| Installment payments-Clinic Acquisitions | - | 378 | 241 | 248 |
| Payment on debt | - | 0 | 0 | - |
| Proceeds from exercise of stock options | - | 0 | - | - |
| Installment payments-Api Fix Ltd | - | 0 | 0 | 0 |
| Installment payments-Medtech | - | 0 | 0 | 0 |
| Payments on mortgage notes | 41 | 39 | 41 | 78 |
| Payments on acquisition notes | 573 | - | - | - |
| Net cash used in financing activities | -614 | -417 | -282 | 24,674 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 313 | 64 | -20 | 304 |
| Net decrease in cash, cash equivalents and restricted cash | -7,375 | 2,736 | -27,721 | 828 |
| Cash, cash equivalents and restricted cash, beginning of year | 21,620 | 18,884 | 45,777 | - |
| Cash, cash equivalents and restricted cash, end of period | 14,245 | 21,620 | 18,884 | - |
ORTHOPEDIATRICS CORP (KIDS)
ORTHOPEDIATRICS CORP (KIDS)